Wykle R L, Malone B, Snyder F
J Biol Chem. 1980 Nov 10;255(21):10256-60.
1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine, derived chemically from choline plasmalogens of beef heart, has been shown to possess powerful antihypertensive activity (Blank, M. L., Synder, F., Byers, L. W., Brooks, B., and Muirhead, E. E. (1979) Biochem. Biophys. Res. Commun. 90, 1194-1200) and to be an extremely potent platelet-activating factor (Demopoulos, C. C., Pinckard, R. N., and Hanahan, D. J. (1979) J. Biol. Chem. 254, 9355-9358). In the present study, microsomal preparations of rat spleen were shown to synthesize 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine by an acetyl-CoA:1-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase reaction; the acetyltransferase appears to be different from the acyltransferase responsible for the transfer of palmitate to glycerolipids. The apparent Km for acetyl-CoA was 67 microM; the optimal concentration of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine was 30 microM. Higher concentrations of the lyso substrate were inhibitory. When acetyl-CoA (100 microM) and 1-hexadecyl-sn-glycero-3-phosphocholine (30 microM) were incubated wih spleen microsomes under optimal conditions, the specific activity was approximately 10 nmol of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine/min/mg of protein. Although the reaction was inhibited by the addition of EDTA or EGTA to the incubation mixture, the acetyltransferase did not appear to require a divalent cation. An acyl analog, 1-palmitoyl-2-lyso-sn-glycero-3-phosphocholine, also served as a substrate for the acetyltransferase; however, the unnatural isomer, 3-alkyl-2-lyso-sn-glycero-1-phosphocholine, did not. The acetyltransferase activity was found in a variety of tissues, but the spleen had the highest activity of the tissues examined; lung, lymph nodes, and thymus also had high activities. Identification of the product and the possible physiological importance of the pathway are discussed.
1-烷基-2-乙酰基-sn-甘油-3-磷酸胆碱是由牛心胆碱缩醛磷脂化学衍生而来,已被证明具有强大的降压活性(Blank, M. L., Synder, F., Byers, L. W., Brooks, B., and Muirhead, E. E. (1979) Biochem. Biophys. Res. Commun. 90, 1194 - 1200),并且是一种极其有效的血小板激活因子(Demopoulos, C. C., Pinckard, R. N., and Hanahan, D. J. (1979) J. Biol. Chem. 254, 9355 - 9358)。在本研究中,大鼠脾脏的微粒体制剂通过乙酰辅酶A:1-烷基-2-溶血-sn-甘油-3-磷酸胆碱乙酰转移酶反应合成1-十六烷基-2-乙酰基-sn-甘油-3-磷酸胆碱;该乙酰转移酶似乎不同于负责将棕榈酸酯转移到甘油脂质上的酰基转移酶。乙酰辅酶A的表观Km为67微摩尔;1-烷基-2-溶血-sn-甘油-3-磷酸胆碱的最佳浓度为30微摩尔。溶血底物浓度较高时具有抑制作用。当在最佳条件下将乙酰辅酶A(100微摩尔)和1-十六烷基-sn-甘油-3-磷酸胆碱(30微摩尔)与脾脏微粒体一起孵育时,比活性约为每分钟每毫克蛋白质10纳摩尔的1-烷基-2-乙酰基-sn-甘油-3-磷酸胆碱。尽管向孵育混合物中添加乙二胺四乙酸(EDTA)或乙二醇双四乙酸(EGTA)会抑制该反应,但乙酰转移酶似乎不需要二价阳离子。一种酰基类似物1-棕榈酰-2-溶血-sn-甘油-3-磷酸胆碱也可作为乙酰转移酶的底物;然而,非天然异构体3-烷基-2-溶血-sn-甘油-1-磷酸胆碱则不能。在多种组织中都发现了乙酰转移酶活性,但在所检测的组织中脾脏的活性最高;肺、淋巴结和胸腺也具有较高的活性。本文讨论了该产物的鉴定以及该途径可能的生理重要性。